SMITH GALE has a total of 13 patent applications. Its first patent ever was published in 2006. It filed its patents most often in United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are MICROGENESYS INC, CODA BIOTHERAPEUTICS INC and THE PIRBRIGHT INST.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology | |
#4 | Organic fine chemistry | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds | |
#5 | Climate change adaptation technologies | |
#6 | Enzymes | |
#7 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Smith Gale | 13 |
#2 | Pushko Peter | 9 |
#3 | Mahmood Kutub | 5 |
#4 | Bright Rick | 4 |
#5 | Zhang Jinyou | 3 |
#6 | Wu Yingyun | 3 |
#7 | Liu Ye | 2 |
#8 | Massare Michael | 2 |
#9 | Zhao Bin | 1 |
#10 | Nathan Margret | 1 |
Publication | Filing date | Title |
---|---|---|
US2013039938A1 | Highly efficient influenza matrix (M1) proteins | |
US2010184192A1 | Avian influenza chimeric VLPS | |
US2010129401A1 | Functional influenza virus like particles (VLPs) | |
US2011008838A1 | Chimeric varicella zoster virus virus-like particles | |
US2009017066A1 | VLPs derived from cells that do not express a viral matrix or core protein | |
US2008233150A1 | Respiratory syncytial virus-virus like particle (vlps) | |
US2010143406A1 | Methods of enhancing protein incorporation into virus like particles | |
US2007184526A1 | Functional influenza virus like particles (VLPs) |